Cargando…

Efficacy of tailored second-line therapy of Helicobacter pylori eradication in patients with clarithromycin-based treatment failure: a multicenter prospective study

BACKGROUND: After the failure of clarithromycin- and bismuth-based quadruple therapy (CBQT), levofloxacin- and bismuth-based quadruple therapy (LBQT) is recommended for Helicobacter pylori eradication. We compared the efficacies of second-line tailored bismuth-based quadruple therapy (TBQT) and empi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Siya, Huang, Keting, Wang, Jun, Wang, Xiaoyong, Yang, Ningmin, Dong, Yu, Zhuang, Ya, Dang, Yini, Zhang, Guoxin, Ye, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456506/ https://www.ncbi.nlm.nih.gov/pubmed/32874206 http://dx.doi.org/10.1186/s13099-020-00378-1

Ejemplares similares

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2016)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020)

The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis
por: Dang, Yini, et al.
Publicado: (2014)

Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection
por: Haji-Aghamohammadi, Ali Akbar, et al.
Publicado: (2016)

Efficacy of Clarithromycin Containing Bismuth–Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication
por: Mokhtare, Marjan, et al.
Publicado: (2015)

Association of MTHFR C677T polymorphism with severity and localization of chronic atrophic gastritis patients without Helicobacter pylori infection: a case control study
por: Kong, Siya, et al.
Publicado: (2020)

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2017)

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
por: Adachi, Kazunori, et al.
Publicado: (2023)

Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in Hemodialysis Patients
por: Jalalzadeh, Mojgan, et al.
Publicado: (2012)

Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin
por: Esmaeili-Dooki, Mohammad Reza, et al.
Publicado: (2015)

Low Dose Furazolidone for Eradication of Helicobacter pylori Instead of Clarithromycin: A Clinical Trial
por: Hajaghamohammadi, Aliakbar, et al.
Publicado: (2015)

First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin
por: Sue, Soichiro, et al.
Publicado: (2017)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis
por: Chang, Young Woon, et al.
Publicado: (2019)

The use of non‐invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance
por: Mommersteeg, Michiel C., et al.
Publicado: (2023)

Antibiotic susceptibility guided reuse of levofloxacin-based therapy in a penicillin-allergic patient for Helicobacter pylori infection: A case report
por: Kong, Siya, et al.
Publicado: (2021)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy
por: Chang, Young Woon, et al.
Publicado: (2020)

Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of helicobacter pylori: A randomized clinical trial
por: Khoshnood, A, et al.
Publicado: (2014)

Response to: Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Sue, Soichiro, et al.
Publicado: (2018)

Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2018)

Microarray-Based Detection and Clinical Evaluation for Helicobacter pylori Resistance to Clarithromycin or Levofloxacin and the Genotype of CYP2C19 in 1083 Patients
por: Song, Yi, et al.
Publicado: (2018)

Application of Visual Gene Clip-Based Tailored Therapy for the Eradication of Helicobacter pylori
por: Yang, Lili, et al.
Publicado: (2021)

Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
por: Choi, Youn I, et al.
Publicado: (2021)

Clarithromycin-Based Standard Triple Therapy Can Still Be Effective for Helicobacter pylori Eradication in Some Parts of the Korea
por: Yoon, Kyu-Hyun, et al.
Publicado: (2014)

Effects of Clarithromycin-Containing Quadruple Therapy on Helicobacter Pylori Eradication after Nitroimidazole-Containing Quadruple Therapy Failure
por: Fakheri, Hafez, et al.
Publicado: (2016)

Levofloxacin based vs clarithromycin based sequential therapy in helicobacter pylori eradication; a randomized clinical trial
por: Moradniani, Mosayeb, et al.
Publicado: (2018)

Helicobacter pylori Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance
por: Seo, Seung In, et al.
Publicado: (2019)

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
por: Azab, Eman T., et al.
Publicado: (2022)

Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
por: Gong, Eun Jeong, et al.
Publicado: (2020)

Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021)

Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains
por: Örsten, Serra, et al.
Publicado: (2023)

Hemorrhagic Colitis Induced by Second-line Helicobacter pylori Eradication
por: Hamada, Yasuhiko, et al.
Publicado: (2019)

Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
por: Ma, Qin, et al.
Publicado: (2022)

Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial
por: Su, Jing, et al.
Publicado: (2017)

Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial
por: Sebghatollahi, Vahid, et al.
Publicado: (2018)

Comparison between different first-line therapy protocols in eradicating Helicobacter pylori in a region with high clarithromycin resistance
por: Yilmaz, Baris, et al.
Publicado: (2018)

Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
por: Chen, Chieh-Chang, et al.
Publicado: (2020)

Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting
por: Kang, Seokin, et al.
Publicado: (2021)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s1h3dlt5agljflt12p5pndodtr